Cost-effectiveness of treating schizophrenia with atypical antipsychotics

被引：0
|
作者：
Lewis, M [1 ]
Frangou, S [1 ]
机构：
[1] Inst Psychiat, Sect Neurobiol Psychosis, London, England
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80332-8
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：338 / 339
页数：2
相关论文
共 50 条
  • [31] Service use and costs of treating schizophrenia with atypical antipsychotics
    Lewis, M
    McCrone, P
    Frangou, S
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (10) : 749 - 756
  • [32] Use of conventional antipsychotics and the cost of treating schizophrenia
    Lyu, RR
    McCombs, JS
    Johnstone, BM
    Muse, DN
    HEALTH CARE FINANCING REVIEW, 2001, 23 (02): : 83 - 99
  • [33] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS OTHER ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA IN FRANCE
    Doutriaux, A.
    Cognet, M.
    Druais, S.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    VALUE IN HEALTH, 2014, 17 (07) : A459 - A459
  • [34] COST-EFFECTIVENESS OF ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR SCHIZOPHRENIA. THE SPANISH PERSPECTIVE
    Garcia-Agua Soler, N.
    Garcia-Ruiz, A. J.
    Martos-Crespo, F.
    Perez-Costillas, L.
    Alcalde de Hoyos, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 70 - 70
  • [35] Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: Implications for schizophrenia treatment
    Neumann, PJ
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 9 - 15
  • [36] Cost-effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France
    Doutriaux, A.
    Druais, S.
    Cognet, M.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S11 - S12
  • [37] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR BIPOLAR DISORDER: THE RUSSIAN PERSPECTIVE
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2013, 16 (03) : A62 - A62
  • [38] Cost-Effectiveness of Adjunctive Therapy with Atypical Antipsychotics for Acute Treatment of Major Depressive Disorder
    Taneja, Charu
    Papakostas, George I.
    Jing, Yonghua
    Baker, Ross A.
    Forbes, Robert A.
    Oster, Gerry
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (05) : 642 - 649
  • [39] MOOD STABILIZERS AND ATYPICAL ANTIPSYCHOTICS IN MAINTENANCE THERAPY FOR BIPOLAR DISORDER: A COST-EFFECTIVENESS ANALYSIS
    Zimmermann, I. R.
    Kiyomoto, H. D.
    Alexandre, R. F.
    Nobre, M. R. C.
    Diaz, M. D. M.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
  • [40] Effectiveness of atypical antipsychotics for substance use in schizophrenia patients
    Swanson, Jeffrey
    Van Dorn, Richard A.
    Swartz, Marvin S.
    SCHIZOPHRENIA RESEARCH, 2007, 94 (1-3) : 114 - 118
12345